111 related articles for article (PubMed ID: 9809482)
1. Effect of YM435, a dopamine DA1 receptor agonist, in a canine model of ischemic acute renal failure.
Yatsu T; Arai Y; Takizawa K; Kasai-Nakagawa C; Takanashi M; Uchida W; Inagaki O; Tanaka A; Takenaka T
Gen Pharmacol; 1998 Nov; 31(5):803-7. PubMed ID: 9809482
[TBL] [Abstract][Full Text] [Related]
2. Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs.
Yatsu T; Arai Y; Takizawa K; Kasai-Nakagawa C; Takanashi M; Uchida W; Inagaki O; Tanaka A; Asano M; Honda K; Takenaka T
Eur J Pharmacol; 1997 Mar; 322(1):45-53. PubMed ID: 9088869
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic characterization of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs.
Yatsu T; Takizawa K; Kasai-Nakagawa C; Uchida W; Tanaka A; Asano M; Honda K; Takenaka T
J Cardiovasc Pharmacol; 1997 Mar; 29(3):382-8. PubMed ID: 9125677
[TBL] [Abstract][Full Text] [Related]
4. Effect of YM435, a novel dopamine DA1 receptor agonist, in a canine model of acute congestive heart failure.
Yatsu T; Arai Y; Sudoh K; Shibasaki M; Uchida W; Inagaki O; Tanaka A; Takenaka T
Gen Pharmacol; 1998 May; 30(5):733-7. PubMed ID: 9559326
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and pharmacokinetic characteristics of YM435, a novel dopamine DA1-receptor agonist, in anaesthetized dogs.
Yatsu T; Miyamoto I; Kaneko-Takanuki F; Watanabe T; Takenaka T
J Pharm Pharmacol; 1997 Sep; 49(9):892-6. PubMed ID: 9306257
[TBL] [Abstract][Full Text] [Related]
6. Dopamine DA1 receptor agonist activity of YM435 in the canine renal vasculature.
Yatsu T; Uchida W; Inagaki O; Tanaka A; Takenaka T
Gen Pharmacol; 1997 Aug; 29(2):229-32. PubMed ID: 9251904
[TBL] [Abstract][Full Text] [Related]
7. 4-(3,4-Dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline derivatives. II. Their renal vasodilation activity and structure-activity relationship.
Anan H; Tanaka A; Tsuzuki R; Yokota M; Yatsu T; Fujikura T
Chem Pharm Bull (Tokyo); 1996 Oct; 44(10):1865-70. PubMed ID: 8904813
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, resolution, and renal vasodilation activity of novel DA1 agonists: 4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline derivatives.
Anan H; Tanaka A; Tsuzuki R; Yokota M; Yatsu T; Honda K; Asano M; Fujita S; Furuya T; Fujikura T
Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2910-4. PubMed ID: 1839245
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435.
Takenaka T; Forster H; Epstein M
J Pharmacol Exp Ther; 1993 Mar; 264(3):1154-9. PubMed ID: 8095547
[TBL] [Abstract][Full Text] [Related]
10. Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats.
Stephens CT; Jandhyala BS
Clin Exp Hypertens; 2002 May; 24(4):301-13. PubMed ID: 12069360
[TBL] [Abstract][Full Text] [Related]
11. Effects of YM435, a novel dopamine D1 receptor agonist, on pancreatic exocrine secretion in anesthetized dogs.
Iwatsuki K; Ren LM; Chiba S
Eur J Pharmacol; 1992 Aug; 218(2-3):237-41. PubMed ID: 1425944
[TBL] [Abstract][Full Text] [Related]
12. Effects of sodium nitroprusside on renal functions and NO-cGMP production in anesthetized dogs.
Tanahashi M; Sekizawa T; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
J Cardiovasc Pharmacol; 1999 Mar; 33(3):401-8. PubMed ID: 10069675
[TBL] [Abstract][Full Text] [Related]
13. Renal effects of atrial natriuretic factor are independent of dopamine1 receptors.
Murphy MB; Bass AS; Goldberg LI
Am J Physiol; 1988 Sep; 255(3 Pt 2):F494-9. PubMed ID: 2970800
[TBL] [Abstract][Full Text] [Related]
14. The effects of fenoldopam on renal blood flow and tubular function during aortic cross-clamping in anaesthetized dogs.
Halpenny M; Markos F; Snow HM; Duggan PF; Gaffney E; O'Connell DP; Shorten GD
Eur J Anaesthesiol; 2000 Aug; 17(8):491-8. PubMed ID: 10998032
[TBL] [Abstract][Full Text] [Related]
15. Preventive effect of zelandopam, a dopamine D1 receptor agonist, on cisplatin-induced acute renal failure in rats.
Yatsu T; Aoki M; Inagaki O
Eur J Pharmacol; 2003 Feb; 461(2-3):191-5. PubMed ID: 12586214
[TBL] [Abstract][Full Text] [Related]
16. Effects of costimulation of dopamine D1- and D2-like receptors on renal function.
Jose PA; Asico LD; Eisner GM; Pocchiari F; Semeraro C; Felder RA
Am J Physiol; 1998 Oct; 275(4):R986-94. PubMed ID: 9756526
[TBL] [Abstract][Full Text] [Related]
17. Effects of NKH477 on endothelin-1-induced renal responses in anaesthetized dogs.
Hara S; Tanahashi M; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):513-5. PubMed ID: 10874508
[TBL] [Abstract][Full Text] [Related]
18. Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs.
Halpenny M; Markos F; Snow HM; Duggan PF; Gaffney E; O'Connell DP; Shorten GD
Crit Care Med; 2001 Apr; 29(4):855-60. PubMed ID: 11373482
[TBL] [Abstract][Full Text] [Related]
19. Effects of hyperosmotic mannitol infusion on hemodynamics of dog kidney.
Behnia R; Koushanpour E; Brunner EA
Anesth Analg; 1996 May; 82(5):902-8. PubMed ID: 8610896
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy of felodipine in two models of acute renal failure in dogs.
Chintala MS; Jandhyala BS
Kidney Int Suppl; 1992 May; 36():S94-9. PubMed ID: 1614075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
